Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.

Boulet GA, Micalessi IM, Horvath CA, Benoy IH, Depuydt CE, Bogers JJ.

J Clin Microbiol. 2010 Jul;48(7):2524-9. doi: 10.1128/JCM.00173-10. Epub 2010 May 12.

2.

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.

Molden T, Kraus I, Skomedal H, Nordstrøm T, Karlsen F.

J Virol Methods. 2007 Jun;142(1-2):204-12. Epub 2007 Mar 26.

PMID:
17379322
3.

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.

Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, Blanc B.

J Clin Virol. 2010 Feb;47(2):177-81. doi: 10.1016/j.jcv.2009.11.011. Epub 2009 Dec 22.

PMID:
20022804
4.

Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts.

Smits HL, van Gemen B, Schukkink R, van der Velden J, Tjong-A-Hung SP, Jebbink MF, ter Schegget J.

J Virol Methods. 1995 Jul;54(1):75-81.

PMID:
7559859
5.

E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.

Hovland S, Muller S, Skomedal H, Mints M, Bergström J, Wallin KL, Karlsen F, Johansson B, Andersson S.

Int J Oncol. 2010 Jun;36(6):1533-9.

PMID:
20428778
6.

HPV detection methods and genotyping techniques in screening for cervical cancer.

Eide ML, Debaque H.

Ann Pathol. 2012 Dec;32(6):e15-23, 401-9. doi: 10.1016/j.annpat.2012.09.231. Epub 2012 Nov 22. Review. English, French.

PMID:
23244480
7.

[Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].

Ardiç N, Oztürk O, Ergünay K, Sezer O.

Mikrobiyol Bul. 2009 Jul;43(3):463-9. Turkish.

PMID:
19795622
8.

Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.

Munkhdelger J, Kim G, Wang HY, Lee D, Kim S, Choi Y, Choi E, Park S, Jin H, Park KH, Lee H.

Exp Mol Pathol. 2014 Oct;97(2):279-84. doi: 10.1016/j.yexmp.2014.08.004. Epub 2014 Aug 4.

PMID:
25102300
9.

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.

Getman D, Aiyer A, Dockter J, Giachetti C, Zhang F, Ginocchio CC.

J Clin Virol. 2009 Jul;45 Suppl 1:S49-54. doi: 10.1016/S1386-6532(09)70008-3.

PMID:
19651369
10.

Use of multiple displacement amplification in the investigation of human papillomavirus physical status.

Evans MF, Adamson CS, von Walstrom GM, Cooper K.

J Clin Pathol. 2007 Oct;60(10):1135-9. Epub 2006 Dec 20.

11.

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.

Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, Skomedal H.

J Clin Microbiol. 2006 Apr;44(4):1310-7.

12.

Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.

Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U.

J Clin Virol. 2012 Apr;53(4):325-31. doi: 10.1016/j.jcv.2011.12.029. Epub 2012 Jan 18.

PMID:
22261122
14.

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary J, Martin C.

J Virol Methods. 2009 Jan;155(1):61-6. doi: 10.1016/j.jviromet.2008.09.027. Epub 2008 Nov 13.

PMID:
18955086
15.

Comparative analysis of three methods for HPV DNA detection in cervical samples.

Michelli E, Téllez L, Mendoza JA, Jürgensen C, Muñoz M, Pérez S, Mosqueda N, Hernández E, Noguera ME, Callejas D, Correnti M, Cavazza ME, Vielma S.

Invest Clin. 2011 Dec;52(4):344-57.

PMID:
22523844
16.

The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities.

Koliopoulos G, Chrelias C, Pappas A, Makridima S, Kountouris E, Alepaki M, Spathis A, Stathopoulou V, Panayiotides I, Panagopoulos P, Karakitsos P, Kassanos D.

Acta Obstet Gynecol Scand. 2012 Jul;91(7):794-801. doi: 10.1111/j.1600-0412.2012.01414.x. Epub 2012 May 15.

PMID:
22486415
17.

Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.

Witt DJ, Kemper M, Stead A, Sillekens P, Ginocchio CC, Espy MJ, Paya CV, Smith TF, Roeles F, Caliendo AM.

J Clin Microbiol. 2000 Nov;38(11):3994-9.

18.

Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.

Andersson S, Hansson B, Norman I, Gaberi V, Mints M, Hjerpe A, Karlsen F, Johansson B.

Int J Oncol. 2006 Sep;29(3):705-11.

PMID:
16865288
19.

NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.

Jeantet D, Schwarzmann F, Tromp J, Melchers WJ, van der Wurff AA, Oosterlaken T, Jacobs M, Troesch A.

J Clin Virol. 2009 Jul;45 Suppl 1:S29-37. doi: 10.1016/S1386-6532(09)70006-X.

PMID:
19651366
20.

Supplemental Content

Support Center